<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font22 { font-size : 22; } .font25 { font-size : 25; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">(). </span>
   <span class="font25">â€" </span>
   <span class="font22">[]. </span>
   <span class="font19">GM-CSF </span>
   <span class="font18">viral </span>
   <span class="font17">furin </span>
   <span class="font15">SARS-CoV- </span>
   <span class="font15">alveolar </span>
   <span class="font14">virus </span>
   <span class="font14">immune </span>
   <span class="font14">response </span>
   <span class="font14">patients </span>
   <span class="font13">cleavage </span>
   <span class="font13">infection </span>
   <span class="font13">expression </span>
   <span class="font13">cell </span>
   <span class="font13">DNA </span>
   <span class="font13">lung </span>
   <span class="font13">influenza </span>
   <span class="font12">[,]. </span>
   <span class="font12">cells </span>
   <span class="font12">clinical </span>
   <span class="font12">pulmonary </span>
   <span class="font12">epithelial </span>
   <span class="font12">human </span>
   <span class="font12">{border-style </span>
   <span class="font12">demonstrated </span>
   <span class="font12">plasmid </span>
   <span class="font12">delivery </span>
   <span class="font12">px;} </span>
   <span class="font12">respiratory </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">shown </span>
   <span class="font12">site </span>
   <span class="font12">therapeutic </span>
   <span class="font12">coronavirus </span>
   <span class="font12">effective </span>
   <span class="font12">mice </span>
   <span class="font12">protein </span>
   <span class="font12">Vigil </span>
   <span class="font12">membrane </span>
   <span class="font11">Immunol.(), </span>
   <span class="font11">activity </span>
   <span class="font11">acute </span>
   <span class="font11">entry </span>
   <span class="font11">proprotein </span>
   <span class="font11">support </span>
   <span class="font11">cancer </span>
   <span class="font11">function </span>
   <span class="font11">host </span>
   <span class="font11">use </span>
   <span class="font11">vaccine </span>
   <span class="font11">clearance </span>
   <span class="font11">high </span>
   <span class="font11">inhibitors </span>
   <span class="font11">ARDS </span>
   <span class="font11">Clin. </span>
   <span class="font11">Mol. </span>
   <span class="font11">RNA </span>
   <span class="font11">Respir. </span>
   <span class="font11">aerosolized </span>
   <span class="font11">factor </span>
   <span class="font11">macrophage </span>
   <span class="font11">related </span>
   <span class="font11">treatment </span>
   <span class="font11">tumor </span>
   <span class="font11">type </span>
   <span class="font11">Biol. </span>
   <span class="font11">However, </span>
   <span class="font11">assessment </span>
   <span class="font11">benefit </span>
   <span class="font11">fusion </span>
   <span class="font11">protease </span>
   <span class="font11">receptor </span>
   <span class="font11">results </span>
   <span class="font11">severe </span>
   <span class="font11">target </span>
   <span class="font11">Chem.(), </span>
   <span class="font11">Med.(), </span>
   <span class="font11">SARS-CoV </span>
   <span class="font11">cases </span>
   <span class="font11">compared </span>
   <span class="font11">early </span>
   <span class="font11">enhances </span>
   <span class="font11">gene </span>
   <span class="font11">glycoprotein </span>
   <span class="font11">mortality </span>
   <span class="font11">pandemic </span>
   <span class="font11">proteins </span>
   <span class="font11">rapid </span>
   <span class="font11">resistance </span>
   <span class="font11">ribavirin </span>
   <span class="font11">testing </span>
   <span class="font11">Am. </span>
   <span class="font11">COVID- </span>
   <span class="font11">Furin </span>
   <span class="font11">IL- </span>
   <span class="font11">[â€"]. </span>
   <span class="font11">activation </span>
   <span class="font11">advanced </span>
   <span class="font11">approach </span>
   <span class="font11">associated </span>
   <span class="font11">critical </span>
   <span class="font11">development </span>
   <span class="font11">disease </span>
   <span class="font11">effects </span>
   <span class="font11">evidence </span>
   <span class="font11">including </span>
   <span class="font11">infection. </span>
   <span class="font11">innate </span>
   <span class="font11">patient </span>
   <span class="font11">pneumonia </span>
   <span class="font11">potential </span>
   <span class="font11">product </span>
   <span class="font11">protection </span>
   <span class="font11">px; </span>
   <span class="font11">responses </span>
   <span class="font11">sequence </span>
   <span class="font11">{font-family </span>
   <span class="font10">aerosol </span>
   <span class="font10">antibody </span>
   <span class="font10">autologous </span>
   <span class="font10">convertases </span>
   <span class="font10">effect </span>
   <span class="font10">enhancement </span>
   <span class="font10">font-size </span>
   <span class="font10">important </span>
   <span class="font10">large </span>
   <span class="font10">load </span>
   <span class="font10">peptide </span>
   <span class="font10">processing </span>
   <span class="font10">production </span>
   <span class="font10">propagation </span>
   <span class="font10">role </span>
   <span class="font10">therapy </span>
   <span class="font10">trial </span>
   <span class="font10">used </span>
   <span class="font10">vitro </span>
   <span class="font10">vivo </span>
   <span class="font10">Aerosolized </span>
   <span class="font10">Biol.(), </span>
   <span class="font10">Cell </span>
   <span class="font10">Ewing's </span>
   <span class="font10">Res.(), </span>
   <span class="font10">Rev. </span>
   <span class="font10">al.GM-CSF </span>
   <span class="font10">colony-stimulating </span>
   <span class="font10">data </span>
   <span class="font10">double; </span>
   <span class="font10">elevated </span>
   <span class="font10">given </span>
   <span class="font10">highly </span>
   <span class="font10">immunotherapy </span>
   <span class="font10">infectious </span>
   <span class="font10">inflammatory </span>
   <span class="font10">inhibition </span>
   <span class="font10">macrophages </span>
   <span class="font10">multiple </span>
   <span class="font10">pDNA </span>
   <span class="font10">particularly </span>
   <span class="font10">pathogens </span>
   <span class="font10">rate </span>
   <span class="font10">repair </span>
   <span class="font10">repurposing </span>
   <span class="font10">revealed </span>
   <span class="font10">similar </span>
   <span class="font10">sites </span>
   <span class="font10">spread </span>
   <span class="font10">syndrome </span>
   <span class="font10">transgenic </span>
   <span class="font10">.GhisoliM </span>
   <span class="font10">BarveM </span>
   <span class="font10">Crit. </span>
   <span class="font10">HIV- </span>
   <span class="font10">Infect. </span>
   <span class="font10">Nat. </span>
   <span class="font10">S/S </span>
   <span class="font10">SARS-CoV-, </span>
   <span class="font10">SARS-CoV-. </span>
   <span class="font10">able </span>
   <span class="font10">advantage </span>
   <span class="font10">allow </span>
   <span class="font10">analysis </span>
   <span class="font10">and/or </span>
   <span class="font10">animal </span>
   <span class="font10">antigenic </span>
   <span class="font10">antiviral </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">cancer. </span>
   <span class="font10">cleaved </span>
   <span class="font10">convertase </span>
   <span class="font10">current </span>
   <span class="font10">dendritic </span>
   <span class="font10">described </span>
   <span class="font10">diagnosed </span>
   <span class="font10">domain </span>
   <span class="font10">factors </span>
   <span class="font10">function, </span>
   <span class="font10">higher </span>
   <span class="font10">identified </span>
   <span class="font10">immunity </span>
   <span class="font10">increased </span>
   <span class="font10">inhalation </span>
   <span class="font10">involving </span>
   <span class="font10">limited </span>
   <span class="font10">medical </span>
   <span class="font10">model </span>
   <span class="font10">novel </span>
   <span class="font10">observed </span>
   <span class="font10">ovarian </span>
   <span class="font10">prevents </span>
   <span class="font10">propeptide </span>
   <span class="font10">provide </span>
   <span class="font10">reported </span>
   <span class="font10">resulting </span>
   <span class="font10">solid; </span>
   <span class="font10">spike </span>
   <span class="font10">studies </span>
   <span class="font10">targeting </span>
   <span class="font10">tissue </span>
   <span class="font10">unique </span>
   <span class="font10">using </span>
   <span class="font10">vaccination </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">â€¢â€¢ </span>
   <span class="font10">AEC </span>
   <span class="font10">Care </span>
   <span class="font10">Expert </span>
   <span class="font10">FDA </span>
   <span class="font10">HIV </span>
   <span class="font10">MERS-CoV </span>
   <span class="font10">Opin. </span>
   <span class="font10">Phase </span>
   <span class="font10">Ther.(), </span>
   <span class="font10">Wuhan, </span>
   <span class="font10">[], </span>
   <span class="font10">active </span>
   <span class="font10">adaptive </span>
   <span class="font10">assembly </span>
   <span class="font10">bi-shRNAfurin </span>
   <span class="font10">bold </span>
   <span class="font10">cells. </span>
   <span class="font10">complex </span>
   <span class="font10">concentration </span>
   <span class="font10">conserved </span>
   <span class="font10">continuous </span>
   <span class="font10">courier; </span>
   <span class="font10">damage </span>
   <span class="font10">day </span>
   <span class="font10">deliver </span>
   <span class="font10">delivered </span>
   <span class="font10">died </span>
   <span class="font10">differentiation </span>
   <span class="font10">distress </span>
   <span class="font10">drug </span>
   <span class="font10">efficacy </span>
   <span class="font10">egress </span>
   <span class="font10">em; </span>
   <span class="font10">enhancing </span>
   <span class="font10">entry, </span>
   <span class="font10">expressed </span>
   <span class="font10">financial </span>
   <span class="font10">formation </span>
   <span class="font10">furin-like </span>
   <span class="font10">identification </span>
   <span class="font10">induced </span>
   <span class="font10">induces </span>
   <span class="font10">infected </span>
   <span class="font10">infections </span>
   <span class="font10">inflammation </span>
   <span class="font10">inhibit </span>
   <span class="font10">interferon </span>
   <span class="font10">intracellular </span>
   <span class="font10">leading </span>
   <span class="font10">lethal </span>
   <span class="font10">levels </span>
   <span class="font10">lungs </span>
   <span class="font10">measles </span>
   <span class="font10">mechanisms </span>
   <span class="font10">metastatic </span>
   <span class="font10">method </span>
   <span class="font10">mice. </span>
   <span class="font10">molecular </span>
   <span class="font10">mouse </span>
   <span class="font10">nebulizer </span>
   <span class="font10">necessary </span>
   <span class="font10">network </span>
   <span class="font10">new </span>
   <span class="font10">outbreak </span>
   <span class="font10">overexpression </span>
   <span class="font10">patients. </span>
   <span class="font10">positive </span>
   <span class="font10">potent </span>
   <span class="font10">powder </span>
   <span class="font10">prior </span>
   <span class="font10">protective </span>
   <span class="font10">provides </span>
   <span class="font10">pt;} </span>
   <span class="font10">recent </span>
   <span class="font10">receptors </span>
   <span class="font10">responsible </span>
   <span class="font10">resulted </span>
   <span class="font10">risk </span>
   <span class="font10">sarcoma. </span>
   <span class="font10">scavenger </span>
   <span class="font10">shRNA </span>
   <span class="font10">significant </span>
   <span class="font10">stimulating </span>
   <span class="font10">surface </span>
   <span class="font10">survival </span>
   <span class="font10">targets </span>
   <span class="font10">therapeutics </span>
   <span class="font10">trans-Golgi </span>
   <span class="font10">transmission </span>
   <span class="font10">vaccines </span>
   <span class="font10">validated </span>
   <span class="font10">vigil </span>
   <span class="font10">viruses </span>
   <span class="font10">worldwide </span>
  </p>
 </body>
</html>
